<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pol3-leuk" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pol3-leuk</book-part-id>
      <title-group>
        <title>POLR3-Related Leukodystrophy</title>
        <alt-title alt-title-type="alt-title">Synonym: 4H Leukodystrophy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bernard</surname>
            <given-names>Genevi&#x000e8;ve</given-names>
          </name>
          <degrees>MD, MSc, FRCPc</degrees>
          <aff>Departments of Neurology and Neurosurgery and Pediatrics, McGill University<break/>Department of Medical Genetics, McGill University Health Center<break/>Child Health and Human Development Program, Research Institute of the McGill University Health Center<break/>Montreal, Quebec, Canada</aff>
          <email>genevieve.bernard@mcgill.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vanderver</surname>
            <given-names>Adeline</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Neurology<break/>Children&#x02019;s Research Institute<break/>Children&#x02019;s Hospital of Philadelphia</aff>
          <email>vandervera@email.chop.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>2</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="me-ataxia" document-type="chapter">
<italic toggle="yes">PRICKLE1</italic>-Related Progressive Myoclonus Epilepsy with Ataxia</related-object>
      <abstract id="pol3-leuk.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions)</p>
            </list-item>
            <list-item>
              <p>Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth)</p>
            </list-item>
            <list-item>
              <p>Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty</p>
            </list-item>
            <list-item>
              <p>Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe</p>
            </list-item>
          </list>
          <p>POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome);</p>
            </list-item>
            <list-item>
              <p>Ataxia, delayed dentition, and hypomyelination (ADDH);</p>
            </list-item>
            <list-item>
              <p>Tremor-ataxia with central hypomyelination (TACH);</p>
            </list-item>
            <list-item>
              <p>Leukodystrophy with oligodontia (LO);</p>
            </list-item>
            <list-item>
              <p>Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).</p>
            </list-item>
          </list>
          <p>Age of onset is typically in early childhood but later-onset cases have also been reported.</p>
          <p>An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in <italic toggle="yes">POL3RA</italic> on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>POLR3-related leukodystrophy is diagnosed by the combination of classic clinical findings, typical brain MRI features, and the presence of biallelic pathogenic variants in <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B,</italic> or <italic toggle="yes">POLR1C</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Individualized care by a multidisciplinary team including a pediatric neurologist, clinical geneticist, physiotherapist, occupational therapist, speech and language pathologist, neuropsychologist, rehabilitation physician, dentist, endocrinologist, ophthalmologist, ear-nose-and-throat specialist, and primary care physician is recommended. Special caution needs to be taken when managing dysphagia in this disorder as it is known to vary widely, even in a single day. Swallowing difficulties will progress over time and dystonia should be monitored and treated to prevent complications and improve the quality of life.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>POLR3-related leukodystrophy is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if both pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pol3-leuk.Diagnosis">
        <title>Diagnosis</title>
        <sec id="pol3-leuk.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>POLR3-related leukodystrophy <bold>should be suspected</bold> in individuals with the following major/shared <bold>clinical features</bold>, which may or may not be present:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic dysfunction: progressive cerebellar features, including:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Gait ataxia, dysarthria, dysmetria, tremor, eye movement abnormalities; and</p>
                </list-item>
                <list-item>
                  <p>To a lesser extent, extrapyramidal (typically dystonia), pyramidal, and cognitive features</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Abnormal dentition (e.g., hypodontia, oligodontia, delayed teeth eruption) [<xref ref-type="bibr" rid="pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty</p>
            </list-item>
            <list-item>
              <p>Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe</p>
            </list-item>
          </list>
          <p>Note: Although this tetrad is highly suggestive of the diagnosis, not all features are present in all individuals who have POLR3-related leukodystrophy.</p>
          <p>
            <bold>Brain MRI findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A hypomyelinating leukodystrophy pattern characterized by T<sub>2</sub> mild hyperintensity of the white matter and T<sub>1</sub> hyperintensity, isointensity, or mild hypointensity of the white matter when compared with grey matter structures [<xref ref-type="bibr" rid="pol3-leuk.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Relative preservation of myelination of specific brain structures, i.e. T<sub>2</sub> hypointense signal (normal or almost normal white matter signal) of the dentate nuclei, anterolateral nuclei of the thalami, globi pallidi, pyramidal tracts in the posterior limbs of the internal capsules, and optic radiations [<xref ref-type="bibr" rid="pol3-leuk.REF.steenweg.2010.2971">Steenweg et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.la_piana.2014.214">La Piana et al 2014</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Variably present: cerebellar atrophy and thinning of the corpus callosum [<xref ref-type="bibr" rid="pol3-leuk.REF.la_piana.2014.214">La Piana et al 2014</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Rarely, an atypical MRI pattern with either</p>
              <list list-type="bullet">
                <list-item>
                  <p>Selective hypomyelination of the corticospinal tracts; or</p>
                </list-item>
                <list-item>
                  <p>Cerebellar atrophy with or without focal hypomyelination [<xref ref-type="bibr" rid="pol3-leuk.REF.la_piana.2016.1622">La Piana et al 2016</xref>]; or</p>
                </list-item>
                <list-item>
                  <p>Involvement of the striata and red nuclei [<xref ref-type="bibr" rid="pol3-leuk.REF.azmanov.2016.4302">Azmanov et al 2016</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>See <xref ref-type="fig" rid="pol3-leuk.F1">Figure 1</xref>.</p>
        </sec>
        <sec id="pol3-leuk.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of POLR3-related leukodystrophy <bold>is established</bold> in a proband with the combination of classic clinical findings, typical brain MRI features, and the identification of biallelic pathogenic variants in <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> on molecular genetic testing (see <xref ref-type="table" rid="pol3-leuk.T.molecular_genetic_testing_us">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p><bold>Serial single-gene testing.</bold> The order of genes to be tested depends on ancestry of the individual:</p>
          <list list-type="bullet">
            <list-item>
              <p>In French-Canadian individuals, sequencing of <italic toggle="yes">POLR3A</italic> should be performed first and followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
              <list list-type="bullet">
                <list-item>
                  <p>If no pathogenic variant is found, sequencing of <italic toggle="yes">POLR3B</italic> is performed, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>For individuals of European ancestry sequencing of <italic toggle="yes">POLR3B</italic> should be performed first.</p>
              <list list-type="bullet">
                <list-item>
                  <p>If a single variant is detected, gene-targeted deletion/duplication analysis of <italic toggle="yes">POLR3B</italic> is done.</p>
                </list-item>
                <list-item>
                  <p>If no pathogenic variant is found, sequencing of <italic toggle="yes">POLR3A</italic> is performed, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>For individuals from the non-French-Canadian and non-European ancestry, sequencing can start with either <italic toggle="yes">POLR3A</italic> or <italic toggle="yes">POLR3B</italic>, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
          </list>
          <p><italic toggle="yes">POLR1C</italic> is tested when sequencing and deletion/duplication analysis of <italic toggle="yes">POLR3A</italic> and <italic toggle="yes">POLR3B</italic> are both negative.</p>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, <italic toggle="yes">POLR1C</italic> with or without other genes of interest (see <xref ref-type="sec" rid="pol3-leuk.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="pol3-leuk.T.molecular_genetic_testing_us" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in POLR3-Related Leukodystrophy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2">Proportion of POLR3-Related Leukodystrophy Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3" id="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLR3A</italic>
                  </td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">41%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLR3B</italic>
                  </td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">49%&#x000a0;<sup>5,&#x000a0;8</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~97%&#x000a0;<sup>5,&#x000a0;8</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~3%&#x000a0;<sup>9</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLR1C</italic>
                  </td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5%&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5%</td>
                  <td headers="hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_1_3 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_1 hd_h_pol3-leuk.T.molecular_genetic_testing_us_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pol3-leuk.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="pol3-leuk" object-id="pol3-leuk.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="pol3-leuk.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="pol3-leuk.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="pol3-leuk.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="pol3-leuk.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="pol3-leuk.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="pol3-leuk.REF.daoud.2013.194">Daoud et al [2013]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.takanashi.2014.259">Takanashi et al [2014]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al [2014]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.la_piana.2016.1622">La Piana et al [2016]</xref></p>
              </fn>
              <fn id="pol3-leuk.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al [2011]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.shimojima.2014.315">Shimojima et al [2014]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.potic.2015.22">Potic et al [2015]</xref></p>
              </fn>
              <fn id="pol3-leuk.TF.1.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="pol3-leuk.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al [2015]</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.jurkiewicz.2015">Jurkiewicz et al [2015]</xref></p>
              </fn>
              <fn id="pol3-leuk.TF.1.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al [2015]</xref>
                </p>
              </fn>
              <fn id="pol3-leuk.TF.1.10">
                <label>10. </label>
                <p>
                  <xref ref-type="bibr" rid="pol3-leuk.REF.thiffault.2015.7623">Thiffault et al [2015]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="pol3-leuk.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="pol3-leuk.Clinical_Description">
          <title>Clinical Description</title>
          <p>POLR3-related leukodystrophy is a hypomyelinating leukodystrophy characterized by neurologic (cerebellar, extrapyramidal, pyramidal, and cognitive) and non-neurologic (dental, endocrine, and ocular) features.</p>
          <p>Before the identification of the involved genes, five overlapping clinical phenotypes were described and are now all recognized as part of the spectrum of POLR3-related leukodystrophy:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>4H syndrome.</bold>
<italic toggle="yes">H</italic>ypomyelination, <italic toggle="yes">h</italic>ypodontia, <italic toggle="yes">h</italic>ypogonadotropic <italic toggle="yes">h</italic>ypogonadism [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2005.1461">Wolf et al 2005</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.timmons.2006.2066">Timmons et al 2006</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.v_zquezl_pez.2008.204">V&#x000e1;zquez-L&#x000f3;pez et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>ADDH.</bold>
<italic toggle="yes">A</italic>taxia, <italic toggle="yes">d</italic>elayed <italic toggle="yes">d</italic>entition, and <italic toggle="yes">h</italic>ypomyelination [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2007.64">Wolf et al 2007</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>TACH.</bold>
<italic toggle="yes">T</italic>remor-<italic toggle="yes">a</italic>taxia with <italic toggle="yes">c</italic>entral <italic toggle="yes">h</italic>ypomyelination [<xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2010.457">Bernard et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.t_treault.2012.122">T&#x000e9;treault et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>LO.</bold>
<italic toggle="yes">L</italic>eukodystrophy with <italic toggle="yes">o</italic>ligodontia [<xref ref-type="bibr" rid="pol3-leuk.REF.atrouni.2003.76">Atrouni et al 2003</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.chouery.2011.73">Chouery et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>HCAHC.</bold>
<italic toggle="yes">H</italic>ypomyelination with <italic toggle="yes">c</italic>erebellar <italic toggle="yes">a</italic>trophy and <italic toggle="yes">h</italic>ypoplasia of the <italic toggle="yes">c</italic>orpus callosum [<xref ref-type="bibr" rid="pol3-leuk.REF.sasaki.2009.582">Sasaki et al 2009</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</xref>]</p>
            </list-item>
          </list>
          <p><bold>Age of onset</bold> is typically in early childhood but later-onset cases have also been reported.</p>
          <p><bold>Neurologic dysfunction</bold> includes prominent cerebellar features leading to progressive gait abnormalities, dysmetria, dysdiadochokinesis, dysarthria, and extraocular movement abnormalities including progressive loss of pursuits (saccadic ocular pursuits), abnormal saccades (i.e., hypo- or hypermetric), and gaze-evoked nystagmus. Progressive vertical more than horizontal gaze restriction has also been reported. Hypersalivation and dysphagia are also commonly seen, typically later in the disease course.</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals may also develop extrapyramidal features &#x02013; almost always dystonia.</p>
            </list-item>
            <list-item>
              <p>Mild pyramidal features are typically present but are not problematic in the vast majority of individuals.</p>
            </list-item>
            <list-item>
              <p>An upper-extremity tremor (usually cerebellar in nature) with or without a dystonic component may be a presenting sign.</p>
            </list-item>
            <list-item>
              <p>Cognitive decline typically occurs later, except in late-onset cases.</p>
            </list-item>
            <list-item>
              <p>Approximately 10% of individuals have later onset and slower progression; they typically present with academic difficulties and cognitive decline which manifests as a plateau in learning at school. Those with later onset may have also behavioral abnormalities.</p>
            </list-item>
          </list>
          <p><bold>Dental abnormalities</bold> include delayed dentition, hypodontia, oligodontia, and eruption of abnormally placed or shaped teeth, among others [<xref ref-type="bibr" rid="pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</xref>]. Dental abnormalities may be subtle and have not been seen in all individuals.</p>
          <p><bold>Endocrine abnormalities.</bold> Hypogonadotropic hypogonadism (HH), the most typical endocrine characteristic, is note seen in all individuals. When reported, HH typically presents with delayed or arrested puberty or absence of early pubertal changes. Other reported endocrine abnormalities include short stature (in 50% of individuals [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>]) and growth hormone deficiency [<xref ref-type="bibr" rid="pol3-leuk.REF.potic.2012.920">Potic et al 2012</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.billington.2015">Billington et al 2015</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.potic.2015.22">Potic et al 2015</xref>].</p>
          <p><bold>Ocular abnormality.</bold> Myopia, typically progressive over several years and eventually leading to severe myopia, is the most common non-neurologic feature.</p>
          <p><bold>Course and life span.</bold> The course of POLR3-related leukodystrophy is invariably progressive. Life span depends on the supportive measures put in place to prevent secondary complications. POLR3-related leukodystrophy is considered to be a life-limiting condition; those with earlier onset are at a higher risk for mortality in young adulthood. Individuals with later onset or with a slower progressive disease course could survive later into adulthood (i.e., 4<sup>th</sup>-5<sup>th</sup> decade).</p>
          <p><bold>Additional features</bold> seen less frequently include the following [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2005.1461">Wolf et al 2005</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.timmons.2006.2066">Timmons et al 2006</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.v_zquezl_pez.2008.204">V&#x000e1;zquez-L&#x000f3;pez et al 2008</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.bekiesinskafigatowska.2010.574">Bekiesinska-Figatowska et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.orcesi.2010.359">Orcesi et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolff.2010.386">Wolff et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.sato.2011.179">Sato et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.potic.2012.920">Potic et al 2012</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Neurologic.</bold> Seizures reported in a minority of individuals [<xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>
                <bold>Ocular</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Optic atrophy</p>
                </list-item>
                <list-item>
                  <p>Cataracts reported in four individuals [<xref ref-type="bibr" rid="pol3-leuk.REF.sato.2011.179">Sato et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Neurophysiologic investigations.</bold> All affected individuals undergoing EMG and nerve conduction studies had normal results [Author, personal observation].</p>
          <p><bold>Wiedemann-Rautenstrauch syndrome</bold> (neonatal progeroid syndrome). A newborn with features of this disorder (including extreme small size, sparse scalp hair, broad abnormally shaped skull, triangular face with midface retraction, natal teeth, decreased subcutaneous fat, and limb contractures) was recently reported to have biallelic truncating variants in <italic toggle="yes">POLR3A</italic> on exome sequencing that were predicted to result in little residual POLR3 function. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other patients with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome [<xref ref-type="bibr" rid="pol3-leuk.REF.jay.2016.3343">Jay et al 2016</xref>].</p>
        </sec>
        <sec id="pol3-leuk.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>
            <bold>
              <italic toggle="yes">POLR3A</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with <italic toggle="yes">POLR3A</italic> pathogenic variants tend to have a later disease onset than those with <italic toggle="yes">POLR3B</italic> pathogenic variants but more rapid disease progression [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>A single female infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have biallelic truncating pathogenic variants in <italic toggle="yes">POLR3A</italic> [<xref ref-type="bibr" rid="pol3-leuk.REF.jay.2016.3343">Jay et al 2016</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>
              <italic toggle="yes">POLR3B</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with <italic toggle="yes">POLR3B</italic> pathogenic variants have earlier disease onset than those with <italic toggle="yes">POLR3A</italic> pathogenic variants but a slower disease course.</p>
            </list-item>
            <list-item>
              <p>Those with <italic toggle="yes">POLR3B</italic> pathogenic variants are more likely to have cerebellar atrophy on MRI and preservation of the myelination of the corticospinal tracts at the level of the internal capsules, compared to individuals with <italic toggle="yes">POLR3A</italic> pathogenic variants.</p>
            </list-item>
            <list-item>
              <p>The common <italic toggle="yes">POLR3B</italic> pathogenic variant c.1568T&#x0003e;A (p.Val523Glu) is very mild. Indeed, individuals homozygous for this variant were either asymptomatic or very mildly symptomatic in early adulthood [<xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>].</p>
            </list-item>
          </list>
          <p><bold><italic toggle="yes">POLR1C.</italic></bold> Limited information is available on individuals with <italic toggle="yes">POLR1C</italic> pathogenic variants.</p>
        </sec>
        <sec id="pol3-leuk.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of POLR3-related leukodystrophy is unknown.</p>
          <p>Individuals with POLR3-related leukodystrophy have been identified worldwide [<xref ref-type="bibr" rid="pol3-leuk.REF.atrouni.2003.76">Atrouni et al 2003</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.sasaki.2009.582">Sasaki et al 2009</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.bekiesinskafigatowska.2010.574">Bekiesinska-Figatowska et al 2010</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.sato.2011.179">Sato et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="pol3-leuk.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">POLR3A</italic> or <italic toggle="yes">POLR3B</italic>.</p>
        <p>Different biallelic pathogenic variants <italic toggle="yes">POLR1C</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="tcs" document-type="chapter">Treacher Collins syndrome</related-object>.</p>
      </sec>
      <sec id="pol3-leuk.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of POLR3-related leukodystrophy includes other hypomyelinating leukodystrophies. See <xref ref-type="table" rid="pol3-leuk.T.hypomyelinating_leukodystrop">Table 2</xref>.</p>
        <table-wrap id="pol3-leuk.T.hypomyelinating_leukodystrop" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Hypomyelinating Leukodystrophies to Consider in the Differential Diagnosis of POLR3-Related Leukodystrophy</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1">Disorder</th>
                <th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2">Gene(s)</th>
                <th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3">MOI</th>
                <th id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features of This Disorder</th>
              </tr>
              <tr>
                <th headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping w/POLR3-related leukodystrophy</th>
                <th headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4" id="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing from POLR3-related leukodystrophy</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pmd" document-type="chapter"><italic toggle="yes">PLP1</italic>-related disorders</related-object>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PLP1</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Variable age of onset</p>
                    </list-item>
                    <list-item>
                      <p>Severe hypomyelination in earlier-onset forms on brain MRI</p>
                    </list-item>
                    <list-item>
                      <p>Prominent cerebellar features in severe &#x02018;connatal&#x02019; form of <italic toggle="yes">PLP1</italic>-related disorders</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Severity ranging from: neonatal presentation w/nystagmus, axial hypotonia evolving into spastic quadraparesis, &#x00026; ataxia (PMD); to an infantile-onset disorder (HEMS); to a later-onset presentation w/spastic paraparesis (SPG2)</p>
                    </list-item>
                    <list-item>
                      <p>Typically, prominent spasticity &#x00026; absence of non-neurologic manifestations seen in POLR3-related leukodystrophy</p>
                    </list-item>
                    <list-item>
                      <p>In HEMS, individuals present w/infantile-onset nystagmus, gait ataxia, axial hypotonia, &#x00026; dysarthria with or without spasticity. They have a characteristic brain MRI pattern w/mild T<sub>2</sub> hyperintensities of the frontoparietal periventricular white matter, optic radiations, medulla oblongata, caudal pons, subcortical cerebellar white matter, hilus of the dentate nucleus, &#x00026; peridentate white matter. A typical pattern of alternating hyper-/hypo-hyperintense stripes on T<sub>2</sub>-weighted imaging can be seen in the posterior limb of the internal capsule.</p>
                    </list-item>
                    <list-item>
                      <p>In later-onset forms (spastic paraparesis), no (or more discrete) abnormalities on brain MRI</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pelizaeus-Merzbacher-like disease<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608804">608804</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GJC2</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Variable age of onset &#x00026; severity</p>
                    </list-item>
                    <list-item>
                      <p>More severe disease in those w/early-infantile onset</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Brain MRI findings similar to those seen in PMD, i.e., diffuse hypomyelination but w/characteristic involvement of the brain stem, in particular the pons</p>
                    </list-item>
                    <list-item>
                      <p>Spastic paraparesis designated as SPG44 in those w/later onset</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="cockayne" document-type="chapter">Classic Cockayne syndrome</related-object>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC6</italic>
                  <break/>
                  <italic toggle="yes">ERCC8</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypomyelination</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Typically, early childhood presentation</p>
                    </list-item>
                    <list-item>
                      <p>Main non-neurologic clinical features: postnatal growth failure, dysmorphic facial traits, propensity to cavities, skin hypersensitivity to sunlight</p>
                    </list-item>
                    <list-item>
                      <p>Neurologic features typically not seen in POLR3-related leukodystrophy: acquired progressive microcephaly, peripheral neuropathy</p>
                    </list-item>
                    <list-item>
                      <p>Delayed myelination (instead of hypomyelination), cerebral atrophy &#x00026; brain calcifications variably seen on MRI</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Trichothiodystrophy&#x000a0;<sup>2</sup><break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS601675">PS601675</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC2</italic>
                  <break/>
                  <italic toggle="yes">ERCC3</italic>
                  <break/>
                  <italic toggle="yes">GTF2H5</italic>
                  <break/>
                  <italic toggle="yes">MPLKIP</italic>
                  <break/>
                  <italic toggle="yes">RNF113A</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR or XL</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Cerebral hypomyelination w/out prominent cerebral atrophy or basal ganglia calcifications on brain MRI</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Variable clinical features including different combinations of:
<list list-type="bullet"><list-item><p>Brittle hair</p></list-item><list-item><p>&#x0201c;Tiger tail&#x0201d; appearance of hair on light microscopy</p></list-item><list-item><p>Skin hypersensitivity to sun exposure</p></list-item><list-item><p>Ichthyosis</p></list-item><list-item><p>Infertility</p></list-item><list-item><p>Neurologic manifestations that may include intellectual disability, microcephaly, ataxia</p></list-item></list></td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="issd" document-type="chapter">Free sialic acid storage disorders</related-object> (including Salla disease &#x00026; intermediate severe Salla disease; excluding infantile free sialic storage disease)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SLC17A5</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Early childhood onset</p>
                    </list-item>
                    <list-item>
                      <p>Cerebellar features</p>
                    </list-item>
                    <list-item>
                      <p>On MRI: hypomyelination w/or w/out thinning of the corpus callosum, cerebellar atrophy</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Variable severity</p>
                    </list-item>
                    <list-item>
                      <p>Progressive facial coarsening</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="hypo-mcc" document-type="chapter">Hypomyelination and congenital cataract</related-object>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FAM126A</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Diffuse hypomyelination on brain MRI</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Onset typically in infancy w/congenital cataracts (variably present) &#x00026; psychomotor regression</p>
                    </list-item>
                    <list-item>
                      <p>Peripheral neuropathy present in most individuals</p>
                    </list-item>
                    <list-item>
                      <p>Diffuse hypomyelination w/superimposed T<sub>1</sub> hypointensities &#x00026; T<sub>2</sub> hyperintensities on brain MRI; cerebellar hemispheres may show mild high T<sub>2</sub> signal resulting in a blurry grey-white matter junction.</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">TUBB4A</italic>-related leukodystrophy (H-ABC)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TUBB4A</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD/DN&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Early-onset motor regression and/or delay</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Prominent extrapyramidal features, more specifically dystonia</p>
                    </list-item>
                    <list-item>
                      <p>Progressive atrophy of the basal ganglia (specifically the putamen) &#x00026; cerebellum characteristically seen on brain MRI</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">18q minus syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601808">601808</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MBP</italic> (haplo-insufficiency caused by deletion at 18q23)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypomyelination</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Differentiated from other hypomyelinating leukodystrophies by multisystemic findings: dysmorphisms; endocrine, cardiac, immune, &#x00026; musculoskeletal abnormalities</p>
                    </list-item>
                    <list-item>
                      <p>2 main white-matter abnormalities on brain MRI: hypomyelination; multifocal T<sub>2</sub> &#x00026; FLAIR hyperintensities</p>
                    </list-item>
                    <list-item>
                      <p>Structural brain abnormalities (heterotopias, <italic toggle="yes">ex vacuo</italic> ventriculomegaly, cerebellar hypoplasia, &#x00026; porencephalic cysts)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Fucosidosis<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/230000">230000</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FUCA1</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypomyelination</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Type 1. Differentiated clinically from the other hypomyelinating leukodystrophies by presence of coarse facial features, hepatosplenomegaly, &#x00026; cardiomegaly</p>
                    </list-item>
                    <list-item>
                      <p>Type 2. Typically differentiated by presence of mild coarsening, growth retardation, &#x00026; angiokeratoma corporis diffusum</p>
                    </list-item>
                    <list-item>
                      <p>On MRI, distinctive hypomyelinating pattern; w/time, atrophy involving both the cerebrum &#x00026; cerebellum, w/hypointensities of the globi pallidi, substantia nigra, &#x00026; thalami</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">DARS</italic>-related leukodystrophy<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615281">615281</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DARS</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Hypomyelinating leukodystrophy</p>
                    </list-item>
                    <list-item>
                      <p>Cerebellar features</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Prominent spasticity of the legs</p>
                    </list-item>
                    <list-item>
                      <p>Involvement of specific tracts on MRI</p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">RARS</italic>-related leukodystrophy<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/616140">616140</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">RARS</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hypomyelinating leukodystrophy</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Prominent spasticity</td>
              </tr>
              <tr>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Peripheral neuropathy, central hypomyelination, Waardenburg syndrome, Hirschsprung disease (PCWH)<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609136">609136</ext-link>)</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SOX10</italic>
                </td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_1_4 hd_h_pol3-leuk.T.hypomyelinating_leukodystrop_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Peripheral demyelinating neuropathy (leading to sensory deficits &#x00026; loss of stretch reflexes)</p>
                    </list-item>
                    <list-item>
                      <p>Hypomyelinating leukodystrophy (leading to early-onset hypotonia, developmental delay, &#x00026; nystagmus evolving over time into spasticity &#x00026; cerebellar ataxia)</p>
                    </list-item>
                    <list-item>
                      <p><related-object link-type="booklink" source-id="gene" document-id="ws1" document-type="chapter">Waardenburg syndrome</related-object> (manifest as pigmentary abnormalities including heterochromia iridis &#x00026; sensorineural hearing loss)</p>
                    </list-item>
                    <list-item>
                      <p>
                        <related-object link-type="booklink" source-id="gene" document-id="hirschsprung-ov" document-type="chapter">Hirschsprung disease</related-object>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>XL = X-linked</p>
            </fn>
            <fn>
              <p>PMD = Pelizaeus-Merzbacher disease</p>
            </fn>
            <fn>
              <p>HEMS = hypomyelination of early myelinating structures</p>
            </fn>
            <fn id="pol3-leuk.TF.2.1">
              <label>1. </label>
              <p>DN = <italic toggle="yes">de novo</italic>. Most affected individuals reported to date have had a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="pol3-leuk.Management">
        <title>Management</title>
        <sec id="pol3-leuk.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with a POLR3-related leukodystrophy, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pediatric neurology consultation</p>
            </list-item>
            <list-item>
              <p>Swallowing assessment</p>
            </list-item>
            <list-item>
              <p>Physiotherapy evaluation</p>
            </list-item>
            <list-item>
              <p>Occupational therapy evaluation</p>
            </list-item>
            <list-item>
              <p>Speech and language pathology assessment</p>
            </list-item>
            <list-item>
              <p>Rehabilitation physician (i.e., physiatrist) consultation</p>
            </list-item>
            <list-item>
              <p>Neuropsychology evaluation</p>
            </list-item>
            <list-item>
              <p>Brain MRI, if not performed at the time of diagnosis</p>
            </list-item>
            <list-item>
              <p>Dentistry consultation</p>
            </list-item>
            <list-item>
              <p>Endocrine consultation</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Ear-nose-and-throat specialist consultation for hypersalivation and swallowing issues</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="pol3-leuk.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Individualized care by a multidisciplinary team including a pediatric neurologist, clinical geneticist, physiotherapist, occupational therapist, speech and language pathologist, neuropsychologist, rehabilitation physician, dentist, endocrinologist, ophthalmologist, ear-nose-and-throat specialist, and primary care physician is recommended.</p>
          <p>Manifestations such as ambulation difficulties and seizures are managed in a routine manner.</p>
          <p>Special caution needs to be taken when managing dysphagia in this disorder as it is known to be quite variable, even in a single day. This is probably due to the prominent cerebellar involvement, leading to more incoordination of swallowing with fatigue, but also with some unpredictability. Dysphagia management is therefore important. Swallowing difficulties will progress over time and individuals may require gastrostomy to manage nutrition.</p>
          <p>Spasticity and dystonia should be monitored and treated to prevent complications and to improve the quality of life.</p>
          <p>Hypersalivation is managed with the multidisciplinary team and an otolaryngologist. Treatment must be individualized. Therapies to consider include rehabilitation (e.g., oromotor therapy, behavioral therapy); medical therapy (e.g., anticholinergic medications, botulinum toxin injections); and, in severe cases, surgery (e.g., relocation of the parotid ducts and relocation of the submandibular ducts with or without sublingual gland excision).</p>
          <p>Learning difficulties are likely to progress slowly. The cognitive involvement is typically much less severe than the motor involvement. In contrast, activities of daily living are likely to become problematic early on in the disease course as motor difficulties make patients progressively more dependent on assistance from others.</p>
          <p>Dental manifestations should be managed, when necessary, by a dentist and/or orthodontist.</p>
          <p>Patients should be followed regularly by an endocrinologist. The decision to treat sex and growth hormone deficiency, when present, should be made on an individual basis.</p>
          <p>Patients need to be followed regularly by an ophthalmologist. A significant proportion of patients will have progressive myopia over several years, which will become severe before stabilizing.</p>
        </sec>
        <sec id="pol3-leuk.Surveillance">
          <title>Surveillance</title>
          <p>No general surveillance guidelines have been developed to date; monitoring should be individualized.</p>
        </sec>
        <sec id="pol3-leuk.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Foods that are likely to lead to choking</p>
            </list-item>
            <list-item>
              <p>Medications acting on D2 receptor blockers (e.g., neuroleptics such as haloperidol or risperidone, anti-nauseous medications such as metoclopramide) as these can exacerbate the extrapyramidal features</p>
            </list-item>
          </list>
        </sec>
        <sec id="pol3-leuk.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="pol3-leuk.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pol3-leuk.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="pol3-leuk.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pol3-leuk.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>POLR3-related leukodystrophy is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="pol3-leuk.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Note: The phenotype is similar among family members; however, the severity can vary.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with POLR3-related leukodystrophy are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> pathogenic variant).</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> pathogenic variant.</p>
        </sec>
        <sec id="pol3-leuk.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="pol3-leuk.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the pathogenic variants in the family. Note: Although the phenotype is similar among family members, the severity and age of onset can vary.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pol3-leuk.Prenatal_Testing_and_Preimplan">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for POLR3-related leukodystrophy are possible.</p>
        </sec>
      </sec>
      <sec id="pol3-leuk.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pol3-leuk.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="pol3-leuk.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Three types of RNA polymerases (Pol I [POLR1], Pol II [POLR2], and Pol III [POLR3]) are responsible for the transcription of DNA into RNA [<xref ref-type="bibr" rid="pol3-leuk.REF.cramer.2008.337">Cramer et al 2008</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.werner.2009.740">Werner et al 2009</xref>]. POLR1, POLR2, and POLR3 have a distinct repertoire of DNA targets. POLR3A and POLR3B are the two largest subunits of POLR3 and form the catalytic core of the polymerase III. POLR1C is a shared subunit to POLR1 and POLR3.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>POLR1</bold> transcribes pre-rRNAs, which are modified into most of the ribosomal RNAs constituting the 18S, 5.8S, and 28S ribosomal subunits.</p>
            </list-item>
            <list-item>
              <p><bold>POLR2</bold> transcribes all protein-coding genes and multiple non-coding genes, including the majority of microRNAs (miRNAs).</p>
            </list-item>
            <list-item>
              <p><bold>POLR3</bold> has a diverse repertoire of nuclear targets and also transcribes exogenous DNA in the cytoplasm.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In the nucleus it transcribes all tRNAs (transfer RNAs), the RNA 7SL (which is necessary for the insertion of proteins into membranes), RNAs 7SK, Alu, and B2 elements (which are responsible for the regulation of the transcription of POLR2).</p>
                </list-item>
                <list-item>
                  <p>POLR3 may play a role in the transcription of some miRNAs, but not to the same extent as POLR2 [<xref ref-type="bibr" rid="pol3-leuk.REF.dieci.2007.614">Dieci et al 2007</xref>].</p>
                </list-item>
                <list-item>
                  <p>POLR3 is responsible for the transcription of the ribosomal subunit 5S gene, which is involved in cytoplasmic and mitochondrial translation [<xref ref-type="bibr" rid="pol3-leuk.REF.szyma_ski.2003.641">Szyma&#x00144;ski et al 2003</xref>].</p>
                </list-item>
                <list-item>
                  <p>POLR3 transcribes vault RNAs, which become the vault organelles (responsible for the transport of the mRNAs from the nucleus to the cytoplasm).</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <sec id="pol3-leuk.POLR3A">
            <title>
              <italic toggle="yes">POLR3A</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">POLR3A</italic> comprises 31 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pol3-leuk" object-id="pol3-leuk.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic variants include missense, nonsense, and splice site variants, small intragenic deletions, and insertions [<xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.potic.2012.920">Potic et al 2012</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.daoud.2013.194">Daoud et al 2013</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.wolf.2014.1898">Wolf et al 2014</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.la_piana.2016.1622">La Piana et al 2016</xref>]. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="pol3-leuk-Tables3-5.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
            <p>No affected individual has been found to have two null pathogenic variants, which may be explained by the role of <italic toggle="yes">POLR3A</italic> as a housekeeping gene, suggesting that some residual POLR3 function is essential for embryonic/fetal survival.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">POLR3A</italic> encodes the DNA-directed RNA polymerase III subunit A (POLR3A) which comprises 1390 amino acids. POLR3A, the largest of the 17 subunits of POLR3, forms (together with POLR3B) the catalytic core of the polymerase.</p>
            <p><bold>Abnormal gene product.</bold> The mapping of the pathogenic variants to protein domains of POLR3A suggests that they can interfere with DNA binding directly, modify the catalytic cleft structure, change POLR3A/POLR3B interaction, and perturb interactions between POLR3A and other POLR3 subunits [<xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</xref>].</p>
            <p>Western blot studies on fibroblasts and brain tissue from an individual with 4H leukodystrophy and known <italic toggle="yes">POLR3A</italic> pathogenic variants showed a statistically significant decrease in POLR3A levels, with a more significant reduction in the cerebral white matter compared to the cortex [<xref ref-type="bibr" rid="pol3-leuk.REF.bernard.2011.415">Bernard et al 2011</xref>].</p>
            <p>These later findings have led us to hypothesize that pathogenic variants in <italic toggle="yes">POLR3A</italic> lead to suboptimal assembly of the POLR3 complex, its translocation in the nucleus and/or interaction with chromatin. This hypothesis is supported by the results published on <italic toggle="yes">POLR1C</italic> leukodystrophy pathogenic variants.</p>
          </sec>
          <sec id="pol3-leuk.POLR3B">
            <title>
              <italic toggle="yes">POLR3B</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">POLR3B</italic> comprises 28 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pol3-leuk" object-id="pol3-leuk.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic variants include missense, nonsense, and splice site variants and small intragenic deletions [<xref ref-type="bibr" rid="pol3-leuk.REF.saitsu.2011.644">Saitsu et al 2011</xref>, <xref ref-type="bibr" rid="pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</xref>]. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="pol3-leuk-Tables3-5.pdf" content-type="local-data">Table 4</inline-supplementary-material> (pdf). Recently, the first examples of large multiexon deletions have been reported [<xref ref-type="bibr" rid="pol3-leuk.REF.gutierrez.2015.69">Gutierrez et al 2015</xref>].</p>
            <p>No affected individual has been found to have two null pathogenic variants, which may be explained by the role of <italic toggle="yes">POLR3B</italic> as a housekeeping gene, suggesting that some residual POLR3 function is essential for embryonic/fetal survival.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">POLR3B</italic> encodes the DNA-directed RNA polymerase III subunit B (POLR3B) which comprises 1133 amino acids. POLR3B, the second largest of the 17 subunits of POLR3, forms (together with POLR3A) the catalytic core of the polymerase.</p>
            <p><bold>Abnormal gene product.</bold> The mapping of the pathogenic variants to protein domains of POLR3B suggests that they can interfere with DNA binding directly, modify the catalytic cleft structure, change POLR3A/POLR3B interaction, and perturb interactions between POLR3B and other POLR3 subunits [<xref ref-type="bibr" rid="pol3-leuk.REF.t_treault.2011.652">T&#x000e9;treault et al 2011</xref>].</p>
          </sec>
          <sec id="pol3-leuk.POLR1C">
            <title>
              <italic toggle="yes">POLR1C</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">POLR1C</italic> comprises nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pol3-leuk" object-id="pol3-leuk.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic leukodystrophy variants reported to date include missense and small intragenic deletions different from the pathogenic variants known to cause <related-object link-type="booklink" source-id="gene" document-id="tcs" document-type="chapter">Treacher Collins syndrome</related-object>. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="pol3-leuk-Tables3-5.pdf" content-type="local-data">Table 5</inline-supplementary-material> (pdf).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">POLR1C</italic> encodes the DNA-directed RNA polymerase I subunit C (POLR1C) which comprises 346 amino acids. POLR1C is a common subunit to both POLR1 and POLR3.</p>
            <p><bold>Abnormal gene product.</bold> The abnormal &#x0201c;leukodystrophy&#x0201d; gene products p.Asn32Ile and p.Asn74Ser alter assembly and nuclear import of POLR3, but not POLR1, leading to decreased binding to POLR3 target genes, and not POLR1 target genes [<xref ref-type="bibr" rid="pol3-leuk.REF.thiffault.2015.7623">Thiffault et al 2015</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="pol3-leuk.References">
        <title>References</title>
        <sec id="pol3-leuk.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pol3-leuk.Literature_Cited.reflist0">
            <ref id="pol3-leuk.REF.atrouni.2003.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Atrouni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daraz&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamraz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caillaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Leukodystrophy associated with oligodontia in a large inbred family: fortuitous association or new entity?</article-title>
                <source>Am J Med Genet A.</source>
                <volume>118A</volume>
                <fpage>76</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12605447</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.azmanov.2016.4302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azmanov</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siira</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamova</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaprelyan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shearwood</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rackham</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bynevelt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grudkova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamenov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svechtarov</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filipovska</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Transcriptome-wide effects of a POLR3A gene mutation in patients with an unusual phenotype of striatal involvement.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2016</year>
                <volume>25</volume>
                <fpage>4302</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">27506977</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.bekiesinskafigatowska.2010.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bekiesinska-Figatowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mierzewska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuczynska-Zardzewialy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczepanik</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obersztyn</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Hypomyelination, hypogonadotropic hypogonadism, hypodontia - First Polish patient.</article-title>
                <source>Brain Dev.</source>
                <volume>32</volume>
                <fpage>574</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19700253</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.bernard.2011.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chouery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putorti</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanohashi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carosso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cl&#x000e9;ment</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abou Ghoch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalkh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorboz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fribourg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teichmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>89</volume>
                <fpage>415</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">21855841</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.bernard.2010.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiffault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putorti</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sylvain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melancon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laframboise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langevin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchard</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebire</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31.</article-title>
                <source>Neurogenetics.</source>
                <volume>11</volume>
                <fpage>457</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20640464</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.billington.2015">
              <mixed-citation publication-type="other">Billington E, Bernard G, Gibson W, Corenblum B. Endrocrine aspects of 4H leukodystrophy: a case report and review of the literature. Case Rep Endocrinol. 2015;2015:314594.</mixed-citation>
            </ref>
            <ref id="pol3-leuk.REF.chouery.2011.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chouery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalkh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salem</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kfoury</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A whole-genome scan in a large family with leukodystrophy and oligodontia reveals linkage to 10q22.</article-title>
                <source>Neurogenetics.</source>
                <volume>12</volume>
                <fpage>73</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20721593</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.cramer.2008.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cramer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armache</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benkert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueckner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damsma</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dengl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geiger</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jasiak</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jawhari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jennebach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamenski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kettenberger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhn</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leike</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sydow</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vannini</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Structure of eukaryotic RNA polymerases.</article-title>
                <source>Annu Rev Biophys.</source>
                <volume>37</volume>
                <fpage>337</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">18573085</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.daoud.2013.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daoud</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gburek-Augustat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Synofzik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Carpintero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism.</article-title>
                <source>J Med Genet.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>194</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23355746</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.dieci.2007.614">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dieci</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiorino</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnuovo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teichmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagano</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The expanding RNA polymerase III transcriptome.</article-title>
                <source>Trends Genet.</source>
                <volume>23</volume>
                <fpage>614</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">17977614</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.gutierrez.2015.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gutierrez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiffault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martos-Moreno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benko</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Spaendonk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2015</year>
                <volume>10</volume>
                <fpage>69</fpage>
                <pub-id pub-id-type="pmid">26045207</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.jay.2016.3343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jay</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiffault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrow</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toriello</surname>
                    <given-names>HV</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2016</year>
                <volume>170</volume>
                <fpage>3343</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">27612211</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.jurkiewicz.2015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunin-Wasowicz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gieruszczak-Bialek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malczyk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Recessive mutations in POLR3B encoding RNA polymerase III subunit causing diffuse hypomyelination in patients with 4H leukodystrophy with polymicrogyria and cataracts.</article-title>
                <source>Clin Neuroradiol.</source>
                <year>2015</year>
                <month>Oct</month>
                <day>19</day>
                <pub-id pub-id-type="pmid">26478204</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.la_piana.2016.1622">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Piana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cayami</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Spaendonk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ounap</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pajusalu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haack</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wassmer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mierzewska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onay</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozkinay</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Diffuse hypomyelination is not obligate for POLR3-related disorders.</article-title>
                <source>Neurology.</source>
                <year>2016</year>
                <volume>86</volume>
                <fpage>1622</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">27029625</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.la_piana.2014.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>La Piana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordish Dressman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murnick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Brain magnetic resonance imaging (MRI) pattern recognition in Pol III-related leukodystrophies.</article-title>
                <source>J Child Neurol.</source>
                <year>2014</year>
                <volume>29</volume>
                <fpage>214</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">24105487</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.orcesi.2010.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uggetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larizza</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balottin</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>New case of 4H syndrome and a review of the literature.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>42</volume>
                <fpage>359</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20399393</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.potic.2012.920">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Potic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choquet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations.</article-title>
                <source>Arch Neurol.</source>
                <volume>69</volume>
                <fpage>920</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22451160</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.potic.2015.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Potic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Popovic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostojic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pekic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophy.</article-title>
                <source>BMC Neurol.</source>
                <year>2015</year>
                <volume>15</volume>
                <fpage>22</fpage>
                <pub-id pub-id-type="pmid">25868523</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.saitsu.2011.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibayama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>89</volume>
                <fpage>644</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">22036171</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.sasaki.2009.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furushima</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum.</article-title>
                <source>Brain Dev.</source>
                <volume>31</volume>
                <fpage>582</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18851904</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.sato.2011.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onuma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uematsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okahashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A case with central and peripheral hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome) plus cataract.</article-title>
                <source>J Neurol Sci.</source>
                <volume>300</volume>
                <fpage>179</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">20884016</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.schiffmann.2009.750">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Invited article: an MRI-based approach to the diagnosis of white matter disorders.</article-title>
                <source>Neurology.</source>
                <volume>72</volume>
                <fpage>750</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19237705</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.shimojima.2014.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimojima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamasaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akaboshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komoike</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Novel compound heterozygous mutations of POLR3A revealed by whole-exome sequencing in a patient with hypomyelination.</article-title>
                <source>Brain Dev.</source>
                <year>2014</year>
                <volume>36</volume>
                <fpage>315</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">23694757</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.steenweg.2010.2971">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steenweg</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bizzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Koning</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Wieringen</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Magnetic resonance imaging pattern recognition in hypomyelinating disorders.</article-title>
                <source>Brain.</source>
                <volume>133</volume>
                <fpage>2971</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">20881161</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.szyma_ski.2003.641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Szyma&#x00144;ski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barciszewska</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdmann</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barciszewski</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>5 S rRNA: structure and interactions.</article-title>
                <source>Biochem J.</source>
                <volume>371</volume>
                <fpage>641</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12564956</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.takanashi.2014.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibayama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Different patterns of cerebellar abnormality and hypomyelination between POLR3A and POLR3B mutations.</article-title>
                <source>Brain Dev.</source>
                <year>2014</year>
                <volume>36</volume>
                <fpage>259</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23643445</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.t_treault.2011.652">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choquet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balottin</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teichmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fribourg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>89</volume>
                <fpage>652</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22036172</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.t_treault.2012.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putorti</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiffault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sylvain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>TACH leukodystrophy: locus refinement to chromosome 10q22.3-23.1.</article-title>
                <source>Can J Neurol Sci.</source>
                <volume>39</volume>
                <fpage>122</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22384513</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.thiffault.2015.7623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thiffault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forget</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choquet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavallee-Adam</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poitras</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sztriha</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Warrenburg</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fribourg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taft</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>III</given-names>
                    <suffix>JR</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Coulombe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.</article-title>
                <source>Nat Commun.</source>
                <year>2015</year>
                <volume>6</volume>
                <fpage>7623</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">26151409</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.timmons.2006.2066">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Timmons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asab</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zirzow</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiss</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanier</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia.</article-title>
                <source>Neurology.</source>
                <volume>67</volume>
                <fpage>2066</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17159124</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.v_zquezl_pez.2008.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>V&#x000e1;zquez-L&#x000f3;pez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Mart&#x000ed;n</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Castro-Castro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzo-Fern&#x000e1;ndez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n-del Valle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e1;rquez-de la Plata</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <comment>[Central hypomyelination, hypogonadotrophic hypogonadism and hypodontia: a new leukodystrophy]</comment>
                <source>Rev Neurol.</source>
                <year>2008</year>
                <volume>47</volume>
                <fpage>204</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18671210</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.werner.2009.740">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Werner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thuriaux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soutourina</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Structure-function analysis of RNA polymerases I and III.</article-title>
                <source>Curr Opin Struct Biol.</source>
                <volume>19</volume>
                <fpage>740</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19896367</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.wolf.2005.1461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harting</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiegand</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt-Mechelke</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zschocke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlenberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rating</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Leukoencephalopathy with ataxia, hypodontia, and hypomyelination.</article-title>
                <source>Neurology.</source>
                <volume>64</volume>
                <fpage>1461</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15851747</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.wolf.2007.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harting</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patzer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeitler</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zschocke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rating</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy.</article-title>
                <source>Neuropediatrics.</source>
                <volume>38</volume>
                <fpage>64</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17712733</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.wolf.2014.1898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Spaendonk</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brais</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catsman-Berrevoets</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kros</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirupathi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stromme</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Grauw</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fribourg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>4H Research Group. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>1898</fpage>
                <lpage>905</lpage>
                <pub-id pub-id-type="pmid">25339210</pub-id>
              </element-citation>
            </ref>
            <ref id="pol3-leuk.REF.wolff.2010.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benzinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Waes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>HU</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Rare dental peculiarities associated with the hypomyelinating leukoencephalopathy 4H syndrome/ADDH.</article-title>
                <source>Pediatr Dent.</source>
                <volume>32</volume>
                <fpage>386</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">21070704</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="pol3-leuk.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="pol3-leuk.Suggested_Reading.reflist0">
            <ref id="pol3-leuk.REF.van_haren.2015.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Haren</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonkowsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suhr</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Consensus statement on preventive and symptomatic care of leukodystrophy patients.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2015</year>
                <volume>114</volume>
                <fpage>516</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">25577286</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pol3-leuk.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pol3-leuk.Author_Notes">
          <title>Author Notes</title>
          <p>Contact information for Dr. Genevi&#x000e8;ve Bernard&#x02019;s laboratory at the Research Institute of the McGill University Health Centre:</p>
          <p><bold>Pediatric Neurodegenerative Laboratory</bold>1001 boul D&#x000e9;carieSite Glen Pavilion E / Block ECHHD Mail Drop Point #EM03211 (cubicle C )Montr&#x000e9;al, QC H4A 3J1Canada</p>
          <p>
            <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Genevieve.bernard@mcgill.ca">Genevieve.bernard@mcgill.ca</email>
          </p>
          <p>514-934-1934 ext. 23380</p>
        </sec>
        <sec id="pol3-leuk.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Drs. Bernard and Vanderver wish to thank all patients and their families as well as all the collaborators who are involved in the POLR3-related leukodystrophy project. Dr. Bernard has received a Research Scholar Junior 1 award from the Fonds de Recherche du Qu&#x000e9;bec en Sant&#x000e9; (FRQS) 2012-2016 and a Canadian Institute of Health Research New Investigator salary award (2017-2022) (201512MSH-360766-171036). She wishes to thank the Canadian Institutes of Health Research (CIHR MOP-G-287547 and MOP-G2-341146-159133-BRIDG), the R&#x000e9;seau de M&#x000e9;decine G&#x000e9;n&#x000e9;tique Appliqu&#x000e9;e (RMGA), the Leuko Dystrophy Foundation, the &#x0201c;Fondation du Grand D&#x000e9;fi Pierre Lavoie&#x0201d;, the European Leukodystrophy Association, and the &#x0201c;Fondation les Amis D&#x02019;Elliot&#x0201d;, for financing her research projects on leukodystrophies. Dr. Vanderver wishes to thank the Intramural Research Program of the National Human Genome Research Institute and the Myelin Disorders Bioregistry Project.</p>
        </sec>
        <sec id="pol3-leuk.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 May 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 August 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>1 March 2012 (av) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="pol3-leuk.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>MRI of the brain of an individual with molecularly confirmed 4H syndromeA. Sagittal T<sub>1</sub>-weighted image (midline) showing cerebellar atrophy (arrowhead) as well as a thin corpus callosum (arrow).B. Axial T<sub>2</sub>-weighted image of the brain at the level of the cerebellum showing hypointensity of the dentate nuclei (arrow).C. Axial T<sub>2</sub>-weighted image of the brain at the level of the basal ganglia showing diffuse hypomyelination as well as hypointensity of the optic radiations (dotted arrow), globi pallidi (arrowhead), and anterolateral nuclei of the thalami (arrow).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pol3-leuk-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
